Rakiba Belkhir

3.0k total citations
28 papers, 814 citations indexed

About

Rakiba Belkhir is a scholar working on Physiology, Rheumatology and Genetics. According to data from OpenAlex, Rakiba Belkhir has authored 28 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Rheumatology and 8 papers in Genetics. Recurrent topics in Rakiba Belkhir's work include Salivary Gland Disorders and Functions (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Rakiba Belkhir is often cited by papers focused on Salivary Gland Disorders and Functions (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Rakiba Belkhir collaborates with scholars based in France, Algeria and Mali. Rakiba Belkhir's co-authors include Xavier Mariette, Raphaèle Séror, Gaëtane Nocturne, S. Le Burel, Laetitia Dunogeant, Laetitia Coutte, Anne-Laure Voisin, Aurélien Marabelle, Olivier Lambotte and O. Fain and has published in prestigious journals such as Annals of Oncology, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Rakiba Belkhir

27 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rakiba Belkhir France 15 339 280 180 159 151 28 814
Barbara Pivetta Italy 13 190 0.6× 90 0.3× 118 0.7× 112 0.7× 130 0.9× 25 781
M. Yadira Hurley United States 15 229 0.7× 120 0.4× 88 0.5× 86 0.5× 56 0.4× 52 651
Takahiro Komori Japan 7 574 1.7× 239 0.9× 248 1.4× 137 0.9× 129 0.9× 12 850
Anna Tassidou Greece 8 105 0.3× 199 0.7× 106 0.6× 115 0.7× 86 0.6× 13 482
Luisa Lorenzi Italy 17 265 0.8× 161 0.6× 65 0.4× 129 0.8× 119 0.8× 49 650
Tomoko Haba Japan 13 169 0.5× 145 0.5× 55 0.3× 141 0.9× 253 1.7× 30 928
Catherine M. Broome United States 14 170 0.5× 416 1.5× 22 0.1× 250 1.6× 170 1.1× 66 1.1k
Pascal Godmer France 13 128 0.4× 114 0.4× 187 1.0× 189 1.2× 67 0.4× 31 802
Bouchra Asli France 15 125 0.4× 78 0.3× 259 1.4× 206 1.3× 88 0.6× 30 1.1k
Warren W. Piette United States 17 100 0.3× 117 0.4× 233 1.3× 77 0.5× 76 0.5× 36 822

Countries citing papers authored by Rakiba Belkhir

Since Specialization
Citations

This map shows the geographic impact of Rakiba Belkhir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakiba Belkhir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakiba Belkhir more than expected).

Fields of papers citing papers by Rakiba Belkhir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakiba Belkhir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakiba Belkhir. The network helps show where Rakiba Belkhir may publish in the future.

Co-authorship network of co-authors of Rakiba Belkhir

This figure shows the co-authorship network connecting the top 25 collaborators of Rakiba Belkhir. A scholar is included among the top collaborators of Rakiba Belkhir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakiba Belkhir. Rakiba Belkhir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bitoun, Samuel, Antoine Rousseau, Marjolaine Gosset, et al.. (2024). Immune Checkpoint Inhibitor-induced Sicca Syndrome. Rheumatic Disease Clinics of North America. 50(2). 291–300. 2 indexed citations
2.
3.
Aldea, Mihaela, Rakiba Belkhir, Émeline Colomba, et al.. (2022). Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report. Frontiers in Immunology. 13. 920130–920130.
4.
Gabison, Éric, Rakiba Belkhir, Gaëtane Nocturne, et al.. (2021). Peripheral ulcerative keratitis in rheumatoid arthritis patients taking tocilizumab: paradoxical manifestation or insufficient efficacy?. Lara D. Veeken. 60(11). 5413–5418. 7 indexed citations
5.
Henry, Julien, et al.. (2021). Denosumab in active Charcot neuro-osteoarthropathy of the foot. Joint Bone Spine. 88(6). 105241–105241. 7 indexed citations
6.
Bitoun, Samuel, Julien Henry, Delphine Desjardins, et al.. (2021). Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases. Arthritis & Rheumatology. 74(6). 927–933. 46 indexed citations
7.
Nocturne, Gaëtane, Julien Henry, Rakiba Belkhir, et al.. (2019). Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy. Lara D. Veeken. 59(6). 1347–1354. 27 indexed citations
8.
Michot, Jean‐Marie, Audrey Simonaggio, Rakiba Belkhir, et al.. (2019). The ImmunoTOX multidisciplinary board: A descriptive study of collaborative management of immune-related adverse events. Annals of Oncology. 30. v719–v719. 4 indexed citations
9.
Belkhir, Rakiba, S. Le Burel, Laetitia Dunogeant, et al.. (2017). Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Annals of the Rheumatic Diseases. 76(10). 1747–1750. 165 indexed citations
10.
Henry, Julien, Jacques‐Eric Gottenberg, Stéphanie Rouanet, et al.. (2017). Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection. Lara D. Veeken. 57(3). 538–547. 33 indexed citations
11.
Rivière, Élodie, Laurent Arnaud, Mikaël Ebbo, et al.. (2017). Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases. The Journal of Rheumatology. 44(7). 1011–1017. 11 indexed citations
12.
13.
Sellam, Jérémie, Raphaèle Séror, Xavier Chevalier, et al.. (2017). SAT0501 Prevalence of hand osteoarthritis in a model of auto-immune disease, sjÖgren syndrome: results of a prospective study. Annals of the Rheumatic Diseases. 76. 965–965. 1 indexed citations
14.
Danion, François, Rakiba Belkhir, J.E. Gottenberg, et al.. (2016). Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease. Lupus. 25(13). 1440–1447. 18 indexed citations
15.
Séror, Raphaèle, Gaëtane Nocturne, Thierry Lazure, et al.. (2015). Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study. Arthritis Research & Therapy. 17(1). 241–241. 34 indexed citations
16.
Payet, Judith, Rakiba Belkhir, Jacques‐Eric Gottenberg, et al.. (2015). ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?. RMD Open. 1(1). e000066–e000066. 30 indexed citations
17.
Nocturne, Gaëtane, Raphaèle Séror, O. Fogel, et al.. (2015). CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome. Arthritis & Rheumatology. 67(12). 3226–3233. 71 indexed citations
18.
Miceli‐Richard, Corinne, Shufang Renault, Saida Boudaoud, et al.. (2015). Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 75(5). 933–940. 72 indexed citations
19.
Gestermann, Nicolas, Mikael Koutero, Rakiba Belkhir, et al.. (2012). Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome. European Cytokine Network. 23(4). 166–172. 18 indexed citations
20.
Belkhir, Rakiba, et al.. (1993). [Congenital C1-esterase inhibitor deficiency. A study of 4 Algerian families].. PubMed. 22(12). 577–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Pivetta Breakdown of academic impact, for papers by M. Yadira Hurley Breakdown of academic impact, for papers by Takahiro Komori Breakdown of academic impact, for papers by Anna Tassidou Breakdown of academic impact, for papers by Luisa Lorenzi Breakdown of academic impact, for papers by Tomoko Haba Breakdown of academic impact, for papers by Catherine M. Broome Breakdown of academic impact, for papers by Pascal Godmer Breakdown of academic impact, for papers by Bouchra Asli Breakdown of academic impact, for papers by Warren W. Piette
Rankless by CCL
2026